Review highlights lifestyle medicine's role in enhancing glycemic control and overall health in adults with T2DM, suggesting improved lifestyle factors can significantly help.
Background: Type 2 diabetes mellitus (T2DM) is a progressive metabolic disorder strongly linked to modifiable lifestyle factors. Lifestyle medicine provides a multidomain, evidence-based framework for prevention and management of T2DM and its complications. Objective: This narrative review synthesizes evidence on six lifestyle medicine domains—diet, physical activity, sleep, smoking cessation, stress management, and social support—in improving glycemic control, insulin sensitivity, and overall health in adults with T2DM. Methods: A PubMed search was conducted using keywords including “type 2 diabetes,” “lifestyle medicine,” “diet,” “physical activity,” “sleep,” “smoking cessation,” “stress,” “mindfulness,” and “social support.” Peer-reviewed English-language studies were prioritized, emphasizing systematic reviews, meta-analyses, randomized controlled trials, and large cohort studies. Relevant guidelines and professional society reports were also reviewed. Results: Carbohydrate-restricted, low-glycemic-index, and Mediterranean diets reduced HbA1c by 0.7–1.8% and fasting glucose by up to 1.3 mmol/L. Aerobic plus resistance training improved HbA1c (~0.7%), HOMA-IR, and VO₂ peak. Optimal sleep (7–8 h) correlated with better glycemic control, while short or long durations worsened HbA1c by 0.2–0.3%. Smoking impaired insulin sensitivity and β-cell function, whereas cessation reduced cardiovascular risk. Stress reduction and mindfulness programs lowered HbA1c by ~0.3% and improved mental health. Social interventions, including structured education and peer support, decreased HbA1c by ~0.25% and reduced isolation-related risks. Conclusion: Lifestyle medicine offers synergistic, non-pharmacological strategies that enhance glycemic control, slow T2DM progression, and improve quality of life. Incorporating these interventions into routine practice is crucial for comprehensive diabetes care.
No takes yet. Share an insight, caveat, or question.
Gąska et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: